Please assess the completion status of the following clinical trial:

Trial Title: Omnipaque Versus Gastroview as Oral Contrast for Abdominal and Pelvic CT

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients at least 19 years of age scheduled for outpatient contrast enhanced abdominal pelvic CT at The Kirklin Clinic in Birmingham Alabama as part of clinical care with the patient's provider will be screened for eligibility.~Exclusion Criteria:~* Not competent to give consent.~* Pregnant.~* Known allergy to either of the contrast agents.~* Loss of sense of taste or smell.~* Contraindication to oral administration such as aspiration risk.

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Gastroview
- 2 (Type: EXPERIMENTAL): Omnipaque

Based on this trial design, predict the completion outcome and termination type (if applicable).